A before-and-after improvement does not isolate one ingredient of a treatment package.
A selected high-dose dependence cohort completed cognitive testing before and after an inpatient program involving slow flumazenil infusion and other treatment. Multiple domains improved over the short observation period compared with baseline.
Fifty patients were selected from a larger high-dose dependence cohort. Cognitive testing before the program was compared with testing after seven days of treatment involving flumazenil, declining clonazepam and other care. Parallel test forms reduced some practice concerns. They could not separate every effect of repeated assessment, withdrawal relief, changed exposure or the inpatient environment, nor establish that improvements persisted after discharge.
The study was not randomized to flumazenil versus an otherwise identical program. Reduced exposure, supportive care, mood changes and repeated testing can contribute; alternative test forms address only part of the practice-effect concern.
Describe the full protocol and selection of participants rather than attributing recovery to a single drug. The findings cannot guarantee normalization, establish long-term durability or support unsupervised withdrawal. Individual cognitive interpretation requires baseline function, actual exposure, symptoms and longitudinal assessment.
Source: PMC7396668, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: High-Dose Benzodiazepine Patients Expressed Mixed Views About Maintenance Treatment.